SCHEMBL1824792

SCHEMBL1824792

Cc1ccc(S(=O)(=O)Oc2ccc(CC(C)NC(=O)c3ccccc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 8/20 0.56
ACACB O00763 1/20 0.55
ALDH1A1 P00352 3/20 0.55
LMNA P02545 1/20 0.55
GAA P10253 1/20 0.54
ENPP1 P22413 2/20 0.53
MEN1 O00255 1/20 0.51
CYP2C9 P11712 1/20 0.51
HPGD P15428 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
ENPP2 Q13822 2/20 0.49
CTSL P07711 1/20 0.49
KDM4E B2RXH2 1/20 0.49
KDM4A O75164 1/20 0.49
ENPP3 O14638 1/20 0.49
TP53 P04637 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824966 0.88 GAA (0.51) P2RX7ACACBALDH1A1LMNAGAA
SCHEMBL1825949 0.87 CTSL (0.55) P2RX7ALDH1A1LMNAENPP1MEN1
SCHEMBL1824282 0.85 ACACB (0.59) ACACBGAAENPP1KDM4EKDM4A
SCHEMBL1822212 0.84 P2RX7 (0.65) P2RX7GAACTSL
SCHEMBL1825424 0.83 ALDH1A1 (0.58) P2RX7ALDH1A1LMNAGAAENPP1
SCHEMBL1828715 0.82 ALDH1A1 (0.47) ALDH1A1LMNAGAAMEN1CYP2C9
SCHEMBL1827363 0.81 SIGMAR1 (0.55) P2RX7ALDH1A1GAAENPP1
SCHEMBL1827496 0.80 P2RX7 (0.54) P2RX7ACACBALDH1A1GAAENPP1
SCHEMBL1825120 0.80 ALDH1A1 (0.55) P2RX7ALDH1A1LMNAENPP1MEN1
SCHEMBL25890576 0.78 ACACB (0.67) ACACBALDH1A1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 P2RX7 3606/4885ACACB 2993/4885ALDH1A1 1099/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 P2RX7 2747/4885ACACB 2259/4885ALDH1A1 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.